First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation
1. 系统已在2025-06-10 14:34:35对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: doi: 10.1182/blood-2017-12-823757
其他信息:
出版社: American Society of Hematology
作者: Rizwan Romee; Sarah Cooley; Melissa M. Berrien-Elliott; Peter Westervelt; Michael R. Verneris; John E. Wagner; Daniel J. Weisdorf; Bruce R. Blazar; Celalettin Ustun; Todd E. DeFor; Sithara Vivek; Lindsey Peck; John F. DiPersio; Amanda F. Cashen; Rachel Kyllo; Amy Musiek; András Schaffer; Milan J. Anadkat; Ilana Rosman; Daniel Miller; Jack O. Egan; Emily K. Jeng; Amy Rock; Hing C. Wong; Todd A. Fehniger; Jeffrey S. Miller
全文下载地址: http://ashpublications.org/blood/article-pdf/131/23/2515/1468513/blood823757.pdf
